InvestorsHub Logo
Followers 278
Posts 12043
Boards Moderated 10
Alias Born 02/09/2003

Re: enzymesarecool post# 4771

Thursday, 12/03/2009 6:58:42 PM

Thursday, December 03, 2009 6:58:42 PM

Post# of 22569
I posted the same sentiment when the Shot Spirits deal with GRBG was first announced: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=42521967

Just on the face of the PR, it is simply "too good to be true" that a company could buy a "controlling interest" in another public company by issuing only $200,000 of restricted stock priced over its recent share price with a valid "expectation" to receive $500,000 in positive cash flow within 60 days of the acquisition.

It's even more unbelievable when one reviews the history of SSPT (formerly SHTP). SSPT shows only $660.00 of gross revenue for the 3 months ending 9/30/09 and only $1,651.00 of gross revenue for the 9 months ending 9/30/09: http://www.pinksheets.com/otciq/ajax/showFinancialReportById.pdf?id=26065 . However, it's especially unbelievable when one reviews the agreement with the Beverage Pouch Group, which give SSPT only 10 cents per case sold.

On the same document as linked to above, see item #14 on page 14. GRBG bought only 51% of SSPT's preferred stock (5,100 of 10,000 preferred shares). That does not seem to be a "controlling interest" in the company. It would also be unusual for the purchaser of preferred shares to receive direct cash flow.

There are so many things that don't make sense in the GRBG press releases surrounding the so-called "acquisition" of SSPT, that no one should take them at face value.

~Cassandra